Fill out the online form on our Patient Registry page to learn more about how you can enroll. Click here to download a printable version of this article/fact sheet: PDF/Word. The Patient…

Watch our Facebook Session from January 25, where FBC’s Research and Education Team, Dr. Mary Sunderland and Dr. Chad Andrews, discussed four vision research and treatment trends to watch for in 2018!…

With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U.S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year…

Yesterday, we helped TMX Group close the market for the 20th Shorcan Charity Day! For the last 20 years, Shorcan Brokers Limited has donated one day’s profits to charities, including Fighting Blindness…

Unless there is a research breakthrough very soon, Shelagh Anson’s children will lose their sight in their teens. Rowan and Caroline were born with Usher Syndrome, a disease that affects hearing and…

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…